Although many diseases have been eradicated or brought under control in the past century or two, public health will always be a major societal challenge. Increased life expectancy has caused a surge in age-related conditions, chronic disease and disability, while developing countries still suffer the burden of HIV/AIDS, malaria and tuberculosis. As the COVID-19 pandemic has clearly demonstrated, it is extremely difficult to contain highly contagious diseases in our global mobile society. It is therefore vital that we prepare for future health challenges while continuing our efforts to address current health issues.

A thorough understanding of the complex biological processes that underlie health and disease is the key to progress in this field. Thanks to their unique properties, neutrons can provide precise information on hydrogen atoms and hydrogen bonding, knowledge that is crucial for understanding the biological function of enzymes and for improving drug efficiency, delivery and formulation. Pharmaceutical companies, like AstraZeneca, BioNTech and NUVISCAN, use neutrons at ILL as a part of their analytical toolbox.

- News,Health,Chemistry,Industry - Pharmaceuticals,Scientific news,D16

A recently published study uses neutron and X-ray scattering to deepen our understanding of freeze-drying protein stabilisation processes, widely used in biopharmaceutical applications. The results obtained for a protein relevant for pharmaceutical…

- Health,Biology Health,Industry - Pharmaceuticals,Scientific news,D22,FIGARO,Austria,France,Italy,Sweden

Understanding the interactions of biomolecules such as proteins or drugs with the membrane of cells is important in biomedical research and for the pharmaceutical industry. The sensitivity of neutrons to hydrogen atoms make neutron scattering a…

- News,Health,Biology Health,Industry - Pharmaceuticals,Scientific news,D11

Courtesy of Alison Oliver (STFC,RAL,ISIS)

- Health,Nuclear and Particle physics,Scientific news,FIPPS,France,Switzerland,United Kingdom

An urgent road trip from Geneva to Grenoble facilitated specialist experiments that could lead to improved cancer treatments.


Courtesy of Professor Patrick Regan / University of Surrey

- Health,Scientific news,D17,FIGARO,Austria,Italy,Spain,Sweden

Courtesy of 2FDN/SFN - written by Yubexi CORREA

- News,Health,Biology Health,Industry - Pharmaceuticals,Scientific news,D22,Sweden,United Kingdom
- News,Health,Industry - Pharmaceuticals,Scientific news,FIGARO
- Health,Biology Health,Industry - Pharmaceuticals,Soft matter,Scientific news,IN13,IN16B,France,Italy
- Highlights 2021,News,Health,Biology Health,Industry - Pharmaceuticals,Scientific news
- Highlights 2021,Health,Biology Health,Industry - Pharmaceuticals,Scientific news